MeChemBio — Collective research (Q11151): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): 1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT., Adding English summary) |
||
Property / summary | |||
1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT. (English) | |||
Property / summary: 1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT. (English) / rank | |||
Normal rank |
Revision as of 07:32, 26 February 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | MeChemBio — Collective research |
Project in Czech Republic financed by DG Regio |
Statements
9,107,700.0 Czech koruna
0 references
13,011,000.0 Czech koruna
0 references
70 percent
0 references
19 January 2017
0 references
31 August 2019
0 references
MedChemBio
0 references
77900
0 references
1.podprojekt pomůže ve fázi výroby hodnocených léčiv. přípravků pro moderní terapie(LPMT). Cílem je zajistit kvalitní výsledky pre-validačních a valid. studií, a vyvinout specif. metody kontroly kvality nových produktů pro dokončení vývoje a zahájení výroby LPMT v režimu SVP. Součástí bude i zahájení studie směřující k identifikaci biomarkerů účinnosti LPMT. a. (Czech)
0 references
1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_079/0008825
0 references